The World Health Organization (WHO) recently confirmed there are no licensed vaccines (or therapeutics) for Ebola disease caused by the Sudan ebolavirus (SUDV.
However, several candidate vaccines appear suitable for human clinical trial evaluation.
As of November 3, 2022, the WHO identified the current vaccine developers and funders who will make SUDV vaccines include, but are not limited to, the University of Oxford, Serum Institute of India, Sabin Vaccine Institute, US Biomedical Advanced Research and Development Authority, US National Institutes of Health, as well as International AIDS Vaccine Initiative and MSD.
The actions taken by the Ministry of Health in the Republic of Uganda and its partners build on past collaboration responding to Zaire ebolavirus outbreaks, another Ebola virus species.
There are U.S. FDA-approved vaccines and treatments for the Zaire ebolavirus, which are listed at PrecisionVaccinations.com/Ebola.
Source link : https://news.google.com/__i/rss/rd/articles/CBMiamh0dHBzOi8vd3d3LnByZWNpc2lvbnZhY2NpbmF0aW9ucy5jb20vMjAyMi8xMS8wNS9zdWRhbi1lYm9sYXZpcnVzLXZhY2NpbmUtY2FuZGlkYXRlcy1wcmVwYXJlLWh1bWFuLXN0dWRpZXPSAW5odHRwczovL3d3dy5wcmVjaXNpb252YWNjaW5hdGlvbnMuY29tLzIwMjIvMTEvMDUvc3VkYW4tZWJvbGF2aXJ1cy12YWNjaW5lLWNhbmRpZGF0ZXMtcHJlcGFyZS1odW1hbi1zdHVkaWVzP2FtcA?oc=5
Publish date : 2022-11-05 17:17:48